Skip to main content
CivicGate

HR 1672
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Maintaining Investments in New Innovation Act

To amend title XI of the Social Security Act to protect access to genetically targeted technologies.

Introduced Feb 27, 2025

Latest action (Feb 27, 2025) Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Policy area
Issues
Economy & Taxes
Legislative subjects (3)

Summary

  • The bill may be cited as the "Maintaining Investments in New Innovation Act."
  • It amends the definition of "qualifying single source drug" in section 1192(e) of the Social Security Act.
  • It extends the qualifying period for "advanced drug products" from 7 years to 11 years.
  • It defines an "advanced drug product" as a drug that uses a genetically targeted technology that may suppress, up-regulate, or activate the function of a gene or its gene product, with the technology defined by reference to section 529A(c)(2) of the Federal Food, Drug, and Cosmetic Act.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

48 cosponsors

Actions (2)

  1. Feb 27, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
  2. Feb 27, 2025 Introduced in House

Full text

IN THE HOUSE OF REPRESENTATIVES

February 27, 2025

Mr. Davis of North Carolina (for himself, Mr. Joyce of Pennsylvania, Mr. Gottheimer, Ms. Tenney, Mr. Yakym, Mr. Morelle, Mr. Hudson, Mr. Bean of Florida, Mrs. Miller-Meeks, Mr. Allen, Ms. Van Duyne, Mr. Peters, Mr. Moore of Utah, and Mr. Crenshaw) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend title XI of the Social Security Act to protect access to genetically targeted technologies.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Maintaining Investments in New Innovation Act”.

SEC. 2. AMENDMENT TO DEFINITION OF QUALIFYING SINGLE SOURCE DRUG.

Section 1192(e) of the Social Security Act (42 U.S.C. 1320f-1(e)) is amended—

(1) in paragraph (1)(A)(ii), by inserting “(or, in the case of an advanced drug product (as defined in paragraph (4)), 11 years)” after “7 years”; and

(2) by adding at the end the following new paragraph:

“(4) Advanced drug product defined.—For purposes of paragraph (1)(A)(ii), the term ‘advanced drug product’ means a drug that incorporates or utilizes a genetically targeted technology (as defined in section 529A(c)(2) of the Federal Food, Drug, and Cosmetic Act) that may result in the modulation (including suppression, up-regulation, or activation) of the function of a gene or its associated gene product.”. <all>

Text versions (1)

  • Introduced in House · Feb 27, 2025

Only one text version is on file, so there’s no earlier version to compare against yet.

More bills on these subjects (8)

Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Comments

Comments

Loading comments…